← Harm reduction

Synthetic Cathinones

The cathinone market in the Netherlands and Germany is currently one of the most unreliable drug markets in Europe. The PK model below applies to mephedrone only — for everything else, the honest answer is we do not have reliable human data.

⚠ Critical market warning — Netherlands and Germany (2025):
PK data disclaimer: The curve below models mephedrone (4-MMC) only, using limited human data. The uncertainty band is intentionally wide — individual variation is larger here than for any other substance on this page. For 2-MMC, 3-MMC, and NEP there is essentially no published human pharmacokinetic data. Do not use this model for those compounds.

Mephedrone (4-MMC) model

kg

Curve models mephedrone only. t½ ~2.5h (range 1.5–3.6h). Wide uncertainty band reflects limited human data.

Dose schedule (mephedrone model)

First dose
75mg
25mg300mg
Total: 75mg(1.07 mg/kg) — mephedrone model
SHOW12h

What is actually in the NL/DE market

The following compounds are what drug checking services actually find — not what products are sold as.

4-MMC (Mephedrone)

Historical

Also known as: meow meow, 4-methylmethcathinone

The original cathinone. Now rarely found in NL/DE market — mostly replaced by 2-MMC and 3-MMC (which themselves are rarely what they claim to be). Has the most human PK data of any cathinone.

~2–3h
PK data quality
⚠ Limited
Effects
Empathogenic (MDMA-like) + stimulant. Strong compulsion to redose.
Key risks
Cardiovascular strain, hyperthermia, neurotoxicity with repeated use, strong psychological dependence.

3-MMC (3-methylmethcathinone)

Common label — rarely genuine

Also known as: poes, miauw, 3M

Almost never what it claims to be. Per Trimbos DIMS 2025, only 3% of samples sold as 3-MMC actually contain 3-MMC. You are almost certainly buying 2-MMC or NEP.

Unknown — no human PK data
PK data quality
❌ No human data
Effects
Similar to mephedrone — stimulant + mild empathogenic. Shorter duration than mephedrone claimed by users.
Key risks
Unknown long-term profile. Extremely high mislabelling rate. NEP contamination is a serious overdose risk.

2-MMC (2-methylmethcathinone)

Most common actual substance

Also known as: the actual content of most "3-MMC"

Currently the most common substance found in samples sold as 3-MMC in the Netherlands (76% of "3-MMC" samples per Trimbos 2025). No published human PK data. Effects described as similar to 3-MMC but possibly more stimulant-dominant.

Unknown
PK data quality
❌ No human data
Effects
Stimulant, less empathogenic than 3-MMC per user reports. Strong redosing compulsion.
Key risks
Essentially unknown toxicology profile. Long-term effects unstudied. Cardiovascular and psychiatric risk assumed similar to other cathinones.

NEP (N-Ethylpentedrone / N-Ethylnorpentedron)

⚠ Dangerous adulterant

Also known as: N-ethylnorpentedrone, α-PEP

Increasingly found in samples sold as 3-MMC — 5% of "3-MMC" samples in NL (Trimbos 2025), actively warned about in Berlin (Sidekicks). Significantly more potent than 2-MMC or 3-MMC. Dosing based on 3-MMC experience leads to overdose.

~3–4h (estimated, very limited data)
PK data quality
⚠ Minimal
Overdose risk: Dosing NEP based on experience with 2-MMC or 3-MMC will likely result in overdose. Significantly more potent.
Effects
Strong stimulant, longer duration than 3-MMC. More pronounced cardiovascular effects. Higher anxiety and paranoia risk.
Key risks
Overdose risk when mistaken for 3-MMC. Heart palpitations, severe anxiety, insomnia, psychotic symptoms at higher doses. High dependence potential.

What was found in samples sold as "3-MMC" — per tested unit

Source: Trimbos DIMS Jaarbericht 2025 — 2025

Each bar shows the % of individually tested samples that contained this substance. A single unit may contain only one of these — results vary per sample.

3-MMC (actual)
3%
2-MMC
76%
NEP
5%
Other / unknown
16%

Dangerous combinations

MAOIsLETHAL

Same as amphetamines and MDMA — massive monoamine release combined with MAOI is potentially fatal. Never combine.

MDMASEVERE

Both release serotonin. Combined serotonergic load substantially increases serotonin syndrome risk and neurotoxicity. Cardiovascular strain is additive to multiplicative.

Other stimulants (cocaine, amphetamines)SEVERE

Additive cardiovascular strain. Combined heart rate and blood pressure elevation. Hyperthermia risk substantially increased.

AlcoholMODERATE–HIGH

Stimulant masks intoxication, leading to alcohol overconsumption. Dehydration risk. Cardiovascular strain from both substances.

KetamineMODERATE–HIGH

Both have dissociative and cardiovascular effects. Combined CNS depression risk. Given the unreliable nature of cathinone market content, combining with ketamine adds a layer of unpredictability about what is actually interacting.

Benzodiazepines (to "come down")MODERATE

Commonly used to manage cathinone comedown. Risk of dependence on both substances. Respiratory depression if combined with alcohol or opioids. Not recommended but if used, avoid combining with other CNS depressants.

Unknown cathinone (high risk given market)UNPREDICTABLE

Given that 97% of "3-MMC" is not 3-MMC, any interaction calculation is meaningless without knowing your actual substance. Drug checking is not optional — it is the only way to have any idea what you are taking.

Concerned about cathinone use? Jellinek.nl, Trimbos.nl, and Drugsinfo.nl offer free, confidential support and up-to-date drug safety information.